First emergency use authorization in the United States for a COVID-19 vaccine booster in individuals 16 years and older. NEW YORK & MAINZ, GER – Pfizer Inc. (NYSE: PFE) and… Read More
VANCOUVER, BC – Recon Health (Vancouver, Canada) today announced its partnership with greenTEG (Zurich, Switzerland) to integrate greenTEG’s proprietary CALERA® core body temperature sensor solution for continuous and non-invasive core… Read More
VANCOUVER, BC – Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed… Read More
Treatment with Cosentyx® (secukinumab) resulted in a 72% reduced flare risk versus placebo, with improvement in disease activity over two years across both enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA)1…. Read More
OncoMyx Therapeutics, a privately-held immuno-oncology platform company, today announced the closing of a $50 million Series B financing, co-led by Lumira Ventures and B Capital Group with participation from LYZZ… Read More
